For Doctors
Whole Genome
Sequencing Technology
Sequences data from 23 pairs of chromosomes to detect trisomies,
sex chromosome abnormalities and selected deletions.
SIMPLE: Requires a minimum of 10 ml of maternal blood - paternal blood is not required for the iGene® NIPT test.
DETECTION OF T21, T18, T13: iGene® NIPT can detect Down Syndrome (T21), Edward Syndrome (T18) and Patau Syndrome (T13)[1].
TURNAROUND TIME: Turnaround time for results is between 7 to 10 working days upon receipt of the blood sample in the laboratory.
iGene® NIPT is powered by BGI Technology
iGene® NIPT is powered by BGI Technology
Accredited Laboratory
iGene® NIPT is tested at iGene Laboratory, a molecular diagnostics laboratory in Singapore, accredited by the College of American Pathologists (CAP) and licensed by the Ministry of Health (Singapore) as a Clinical Laboratory (License Number: 17I0382/02/192).
Quality Standards
iGene Laboratory participates in proficiency testing under the international External Quality Assessments (EQA) from CAP and GenQA (formerly known as UK NEQAS), to ensure reliable results.
Ordering iGene® NIPT
1
Complete Request Form
Please go through the iGene® NIPT Consent Form with your patient and complete the iGene® NIPT Request & Consent Form. Pre-test and Post-test counselling is recommended.
2
Collect Blood Sample
Draw a minimum of 10 ml of patient's blood (21G needle recommended) into a Streck Tube vacutainer, then place the Streck Tube into the biohazard bag and send it to iGene Laboratory. Turnaround time for sample processing is between 7 to 10 working days from receipt of sample in the laboratory.
Note: Do not chill the Streck Tube.
3
Receive Report
When you receive your patient’s report, it is reported as “Screen Negative” or “Screen Positive”.
If the result is “Screen Positive”, it is recommended that your patient undergo further confirmatory by diagnostics testing such as amniocentesis, which is an invasive test[2]. This is because iGene® NIPT is a screening and not a diagnostic test.
iGene® NIPT is powered by BGI Technology
Frequently Asked Questions (FAQs)
Reference:
1. Zhang H, et al. (2015) Ultrasound Obstet. & Gynecol. 10.1002/uog/14792.
2. Gregg, A. R., et al. (2016). Noninvasive prenatal screening for fetal aneuploidy, 2016 update: A position statement of the American College of Medical Genetics and Genomics. Genetics in Medicine. doi:10.1038/gim.2016.97
iGene® NIPT is powered by BGI Technology